Financial Year |
March 31 2023 |
Monetary Funds |
2,096,334,255.74 |
Held-for-trading Financial Assets |
667,128,872.16 |
Notes Receivable |
-- |
Accounts Receivable |
383,298,832.55 |
Advances to Suppliers |
94,160,124.62 |
Other Receivables |
44,611,079.09 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
355,362,865.58 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
10,244,614.09 |
Total Current Assets |
4,076,208,380.95 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
36,088,979.04 |
Investment Properties |
-- |
Fixed Assetes |
1,065,202,939.44 |
Under-construction Projects |
467,339,600.23 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
374,742,752.32 |
R&D expenses |
2,547,169.82 |
Goodwill |
41,741,918.10 |
Long-Term Deferred and Prepaid Expenses |
2,344,359.14 |
Deferred Income Tax Assets |
40,842,578.47 |
Other Non-Current Assets |
69,147,569.05 |
Sub-Total of Non-Current Assets |
2,240,741,100.11 |
Total Assets |
6,316,949,481.06 |
Short-Term Loans |
-- |
Trading Financial liabilities |
-- |
Notes Payable |
11,490,498.94 |
Accounts Payable |
205,846,542.04 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
97,407,639.03 |
Taxes Payable |
84,138,653.03 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
881,897,579.17 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
2,064,560.36 |
Other Current Liabilities |
20,613,554.93 |
Sub-Total of Current Liabilities |
1,473,621,799.63 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
21,009,653.87 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
87,487,583.09 |
Total Liabilities |
1,561,109,382.72 |
Paid-In Capital(Or Share Stock) |
629,548,958.00 |
Capital Surplus |
414,657,957.92 |
Surplus Reserve |
356,393,488.23 |
LESS:Treasury Stock |
31,328,382.20 |
Undistributed Profits |
2,764,972,473.20 |
Minority Stockholder's Interest |
621,595,603.19 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,134,244,495.15 |
Owner's Equity(Stockholder's Equity) |
4,755,840,098.34 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
6,316,949,481.06 |